Case Control Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jan 18, 2017; 9(2): 91-98
Published online Jan 18, 2017. doi: 10.4254/wjh.v9.i2.91
Table 3 Comparison between subjects with fibrosis degree F < 3 and subjects with advanced fibrosis degree F ≥ 3 (mean ± SD, unless otherwise stated)
VariableF < 3 (n = 47)F ≥ 3 (n = 30)P
Gender (male) %36.263.30.020
Age (yr)42.47 ± 1443.07 ± 11.090.836
Education (yr)13.19 ± 2.5914.03 ± 2.550.166
BMI (kg/m2)40.68 ± 3.9642.32 ± 5.30.023
Type 2 diabetes drugs (%)17200.741
All sugared soft drinks (cups/d)1.64 ± 2.451.37 ± 2.460.635
Carbonated sugared drinks intake (cups/d)0.9 ± 1.550.98 ± 2.160.850
Diet carbonated drinks intake (cups/d)0.73 ± 1.440.68 ± 1.330.890
Coffee intake (cups/d)1.96 ± 1.881.93 ± 1.690.951
Alcohol (servings/wk)0.87 ± 1.760.33 ± 1.470.152
Current or past smokers (%)48.946.70.846
Fruits intake (portions/d)1.57 ± 1.251.97 ± 1.40.204
Vegetables intake (portions/d)2.43 ± 2.113.12 ± 2.070.162
Fried food intake (portions/d)1.12 ± 1.121.12 ± 0.750.999
Leisure time physical activity (min/wk)155.62 ± 89.96355.71 ± 585.970.403
Sedentary time1 (min/d)265.66 ± 178.79261.00 ± 176.010.911
Daily activity (score2)20.32 ± 3.4920.93 ± 3.450.452
Glucose (mg/dL)117 ± 39.93116.53 ± 27.080.964
Total cholesterol (mg/dL)197.75 ± 37.39180.41 ± 250.083
LDL (mg/dL)117.81 ± 35.94101.61 ± 22.000.087
HDL (mg/dL)44.85 ± 11.1642.82 ± 13.60.619
Triglycerides (mg/dL)176.28 ± 55.14194.57 ± 58.840.328
ALT (U/L)36.5 ± 33.2655.76 ± 56.260.147
AST (U/L)26.89 ± 21.9931.89 ± 17.110.409
GGT (U/L)29.89 ± 26.2543.4 ± 16.960.241